Your browser is no longer supported. Please, upgrade your browser.
VIR Vir Biotechnology, Inc. daily Stock Chart
VIR [NASD]
Vir Biotechnology, Inc.
Index- P/E- EPS (ttm)-6.21 Insider Own4.20% Shs Outstand108.39M Perf Week4.07%
Market Cap6.32B Forward P/E- EPS next Y-2.34 Insider Trans-8.77% Shs Float106.55M Perf Month4.86%
Income-223.30M PEG- EPS next Q-0.62 Inst Own36.20% Short Float3.28% Perf Quarter74.03%
Sales10.10M P/S625.87 EPS this Y-443.30% Inst Trans12.72% Short Ratio2.38 Perf Half Y188.71%
Book/sh3.51 P/B15.00 EPS next Y8.20% ROA- Target Price34.67 Perf Year-
Cash/sh2.96 P/C17.78 EPS next 5Y- ROE- 52W Range11.65 - 75.00 Perf YTD318.77%
Dividend- P/FCF- EPS past 5Y- ROI-41.90% 52W High-29.79% Beta-
Dividend %- Quick Ratio6.70 Sales past 5Y- Gross Margin- 52W Low352.00% ATR3.02
Employees237 Current Ratio6.70 Sales Q/Q54.10% Oper. Margin- RSI (14)65.63 Volatility6.47% 6.16%
OptionableYes Debt/Eq0.00 EPS Q/Q-171.90% Profit Margin- Rel Volume0.73 Prev Close53.20
ShortableYes LT Debt/Eq0.00 EarningsAug 11 AMC Payout- Avg Volume1.47M Price52.66
Recom3.20 SMA205.77% SMA5021.03% SMA20082.96% Volume1,064,109 Change-1.02%
Mar-19-20Downgrade JP Morgan Neutral → Underweight $26
Mar-13-20Downgrade Goldman Buy → Neutral
Feb-27-20Downgrade Robert W. Baird Neutral → Underperform $17
Feb-04-20Downgrade JP Morgan Overweight → Neutral $25 → $26
Nov-14-19Initiated Robert W. Baird Neutral
Nov-05-19Initiated JP Morgan Overweight $25
Nov-05-19Initiated Goldman Buy $37
Nov-05-19Initiated Cowen Outperform
Nov-05-19Initiated Barclays Overweight $25
Aug-11-20 04:01PM  
06:40AM  
Jul-28-20 04:01PM  
Jul-10-20 04:02PM  
04:01PM  
Jul-07-20 10:25PM  
05:58PM  
Jul-06-20 07:00AM  
Jun-08-20 02:06PM  
Jun-05-20 01:22PM  
Jun-04-20 03:57PM  
Jun-02-20 08:00AM  
Jun-01-20 12:23PM  
11:00AM  
May-29-20 08:00AM  
May-27-20 08:00AM  
May-23-20 08:13AM  
May-19-20 09:31AM  
May-18-20 05:28PM  
05:00PM  
02:47PM  
05:05AM  
May-15-20 03:09PM  
01:03PM  
May-12-20 04:01PM  
May-08-20 04:01PM  
May-07-20 04:01PM  
May-05-20 03:26PM  
03:11PM  
May-04-20 10:23AM  
08:24AM  
07:30AM  
Apr-28-20 08:00AM  
Apr-16-20 08:09AM  
Apr-15-20 04:01PM  
Apr-08-20 10:05AM  
07:00AM  
Apr-07-20 11:00AM  
Apr-06-20 04:03PM  
09:56AM  
08:12AM  
08:01AM  
Mar-30-20 07:00AM  
Mar-26-20 04:01PM  
10:52AM  
10:09AM  
08:23AM  
Mar-25-20 08:00AM  
Mar-18-20 05:49PM  
Mar-17-20 02:26PM  
Mar-16-20 03:41PM  
Mar-13-20 12:40PM  
11:01AM  
Mar-12-20 10:36AM  
10:07AM  
09:01AM  
08:00AM  
Mar-11-20 08:00AM  
Mar-10-20 08:25PM  
Mar-06-20 07:43AM  
Mar-05-20 09:19AM  
08:22AM  
Mar-04-20 03:38PM  
08:40AM  
07:37AM  
Mar-02-20 09:08AM  
Feb-28-20 02:14PM  
10:28AM  
Feb-27-20 04:29PM  
10:18AM  
Feb-25-20 09:16AM  
08:30AM  
Feb-24-20 08:47PM  
Feb-12-20 08:30AM  
Jan-24-20 05:57PM  
08:55AM  
Jan-23-20 10:18AM  
07:24AM  
Jan-22-20 05:45PM  
Jan-13-20 08:00AM  
Jan-09-20 08:00AM  
Jan-07-20 05:09PM  
Nov-19-19 04:15PM  
Nov-07-19 09:16AM  
Oct-25-19 01:16AM  
Oct-11-19 05:01PM  
12:48PM  
Oct-10-19 07:41PM  
04:15PM  
Oct-09-19 08:53AM  
Oct-07-19 07:53AM  
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; and VIR-2020 for the prevention of tuberculosis. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; a collaboration, license, and option agreement with Visterra, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; a collaboration with WuXi Biologics; and a collaborative research agreement with Generation Bio., as well as GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline Biologicals SA., and Alnylam Pharmaceuticals, Inc. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies for potential COVID-19 treatment. Vir Biotechnology, Inc. was founded in 2016 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pang PhillipChief Medical OfficerAug 05Option Exercise1.5812,50019,68828,277Aug 07 05:07 PM
Pang PhillipChief Medical OfficerAug 05Option Exercise1.5812,50019,68828,277Aug 07 05:40 PM
Pang PhillipChief Medical OfficerAug 05Sale50.9012,500636,22215,777Aug 07 05:07 PM
Pang PhillipChief Medical OfficerAug 05Sale50.9012,500636,22215,777Aug 07 05:40 PM
Parrish JayChief Business OfficerAug 03Option Exercise1.5011,11016,665233,332Aug 04 05:14 PM
Parrish JayChief Business OfficerAug 03Sale47.6511,110529,404222,222Aug 04 05:14 PM
Virgin HerbertEVP, Research & CSOJul 28Option Exercise1.537,90012,0877,900Jul 30 07:28 PM
Virgin HerbertEVP, Research & CSOJul 28Option Exercise1.537,90012,0877,900Jul 30 07:03 PM
Virgin HerbertEVP, Research & CSOJul 28Sale47.997,900379,0900Jul 30 07:03 PM
Virgin HerbertEVP, Research & CSOJul 28Sale47.997,900379,0900Jul 30 07:28 PM
Pang PhillipChief Medical OfficerJul 15Option Exercise2.2412,50028,01828,277Jul 16 05:00 PM
Pang PhillipChief Medical OfficerJul 15Sale49.5312,500619,11815,777Jul 16 05:00 PM
Virgin HerbertEVP, Research & CSOJul 14Option Exercise1.537,90012,0877,900Jul 16 05:00 PM
Virgin HerbertEVP, Research & CSOJul 14Sale48.857,900385,8760Jul 16 05:00 PM
Horn HowardCFOJul 13Sale50.0630,0001,501,731177,777Jul 15 04:50 PM
Horn HowardCFOJul 02Sale40.0010,000400,000207,777Jul 02 06:42 PM
Parrish JayChief Business OfficerJul 01Option Exercise1.5475,000115,792297,222Jul 02 06:43 PM
Pang PhillipChief Medical OfficerJul 01Option Exercise4.3712,50054,68728,277Jul 02 06:42 PM
Parrish JayChief Business OfficerJul 01Sale37.9575,0002,846,310222,222Jul 02 06:43 PM
Horn HowardCFOJul 01Sale37.8410,000378,399217,777Jul 02 06:42 PM
Pang PhillipChief Medical OfficerJul 01Sale37.7812,500472,25215,777Jul 02 06:42 PM
Horn HowardCFOJun 25Sale50.0030,0001,500,000227,777Jun 26 05:00 PM
Virgin HerbertEVP, Research & CSOJun 24Option Exercise1.539,36014,3219,360Jun 24 08:23 PM
Virgin HerbertEVP, Research & CSOJun 24Sale48.009,360449,2800Jun 24 08:23 PM
Virgin HerbertEVP, Research & CSOJun 23Option Exercise1.535,5608,5075,560Jun 24 08:23 PM
Virgin HerbertEVP, Research & CSOJun 23Sale38.995,560216,7780Jun 24 08:23 PM
Virgin HerbertEVP, Research & CSOJun 19Option Exercise1.533,5105,3703,510Jun 23 05:00 PM
Horn HowardCFOJun 19Sale40.0010,000400,000257,777Jun 23 05:00 PM
Virgin HerbertEVP, Research & CSOJun 19Sale38.003,510133,3840Jun 23 05:00 PM
Pang PhillipChief Medical OfficerJun 17Option Exercise5.1812,50064,68828,277Jun 18 05:00 PM
Pang PhillipChief Medical OfficerJun 17Sale37.2712,500465,81515,777Jun 18 05:00 PM
Virgin HerbertEVP, Research & CSOJun 09Option Exercise1.533,8055,8223,805Jun 11 05:00 PM
Virgin HerbertEVP, Research & CSOJun 09Sale36.283,805138,0300Jun 11 05:00 PM
Pang PhillipChief Medical OfficerJun 03Option Exercise5.1812,50064,68828,277Jun 04 04:53 PM
Pang PhillipChief Medical OfficerJun 03Sale35.0712,500438,38715,777Jun 04 04:53 PM
Parrish JayChief Business OfficerJun 01Option Exercise1.4975,000111,375297,222Jun 02 09:15 PM
Parrish JayChief Business OfficerJun 01Sale35.2275,0002,641,410222,222Jun 02 09:15 PM
Horn HowardCFOJun 01Sale35.1010,000351,038267,777Jun 02 09:14 PM
Virgin HerbertEVP, Research & CSOMay 26Option Exercise1.533,8055,8223,805May 27 05:00 PM
Virgin HerbertEVP, Research & CSOMay 26Sale34.083,805129,6740May 27 05:00 PM
Virgin HerbertEVP, Research & CSOMay 18Option Exercise1.531,7552,6851,755May 19 05:21 PM
Virgin HerbertEVP, Research & CSOMay 18Sale38.001,75566,6900May 19 05:21 PM
Virgin HerbertEVP, Research & CSOMay 14Option Exercise1.533,8055,8223,805May 15 07:48 PM
Parrish JayChief Business OfficerMay 14Option Exercise1.4975,000111,375297,222May 15 07:18 PM
Parrish JayChief Business OfficerMay 14Sale30.0575,0002,253,885222,222May 15 07:18 PM
Virgin HerbertEVP, Research & CSOMay 14Sale30.073,805114,4180May 15 07:48 PM
MORE ROBERT JDirectorMay 01Sale28.0018,458516,85371,534May 05 05:55 PM
Pang PhillipChief Medical OfficerApr 17Option Exercise0.868,0006,84015,777Apr 20 08:20 PM